Myasthenia gravis is a rare neurological autoimmune disease characterized by fluctuating muscle weakness that worsens with activity. About 17,000 people in Germany suffer from the disease. Many struggle to access appropriate care, especially if they need complex immunotherapies. The start-up RareLink now aims to address this gap with its MyaLink…
With the support of SPARK-BIH and the BIH Biomedical Innovation Academy (BIA), the first cohorts in the project and personal funding programs of the National Strategy for Gene- and Cell-Based Therapies (GCT) have been selected. Within the project funding according to the SPARK method, 17 projects from 13 cities throughout Germany are being funded…
Translational research with immediate impact: A group around Dr. Sören Lukassen and colleagues developed an AI model that can quickly and reliably detect the epigenetic finger print of tumors in tissue samples or from body fluids. With this a diagnosis is possible without a biopsy, which can be risky e.g. with a brain tumor.
The Deutsche Forschungsgemeinschaft (DFG) and Wissenschaftsrat (WR) announced that the Excellence Cluster NeuroCure, which has operated since 2007, can continue its work. NeuroCure aims to improve our understanding of neurological and psychiatric diseases and works to translate results into therapies (German-language).
Joining 54 other biomedical and health scientists, Prof. Claudia Langenberg, head of the group for Computational Medicine, receives the fellowship for the Academy of Medical Sciences for her excellent work in public health and precision medicine.
A team around Mine Koprulu and Claudia Langenberg at the BIH and Queen Mary University of London’s Precision Healthcare University Research Institute (PHURI) shed new light the underlying biological mechanisms which cause differences in health risks, symptoms and outcomes between males and females.
Aiming to bridge the gap between cutting-edge biomedical research and real-world clinical application, the Berlin Institute of Health at Charité (BIH) entered into an agreement with BioLabs, an internationally known innovation laboratory platform with a network of shared lab and office workspaces, to support operations at the full-service BIH…
Improving healthcare, relieving the burden on medical professionals and advancing research in Germany: These are the goals of the three-year research project “FHIR-Starter” starting in February 2025. The project focuses on the development of a software service that is able to automatically structure medical data using large language models (LLMs).…
A group of Berlin researchers in collaboration with international scientists have found differences in heart inflammation caused by COVID-19, anti-COVID-19 vaccination, and non-COVID-19 myocarditis. The find paves the way for more personalized therapies, they report in “Nature Cardiovascular Research.”
